Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial

Jan-Stephan F. Sanders; Anoek A. E. de Joode; Ruud G. DeSevaux; Jan Broekroelofs; Alexandre E. Voskuyl; Pieter van Paassen; Cees G. M. Kallenberg; Jan Willem Cohen Tervaert; Coen A. Stegeman

doi:10.1093/ndt/gfw211

Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial

Jan-Stephan F. Sanders, Anoek A. E. de Joode, Ruud G. DeSevaux, Jan Broekroelofs, Alexandre E. Voskuyl, Pieter van Paassen, Cees G. M. Kallenberg, Jan Willem Cohen Tervaert, Coen A. Stegeman

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1453-1459
Journal	Nephrology, Dialysis, Transplantation
Volume	31
Issue number	9
DOIs	https://doi.org/10.1093/ndt/gfw211
Publication status	Published - Sep 2016

Access to Document

10.1093/ndt/gfw211

Cite this

Sanders, J-S. F., de Joode, A. A. E., DeSevaux, R. G., Broekroelofs, J., Voskuyl, A. E., van Paassen, P., Kallenberg, C. G. M., Tervaert, J. W. C., & Stegeman, C. A. (2016). Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. Nephrology, Dialysis, Transplantation, 31(9), 1453-1459. https://doi.org/10.1093/ndt/gfw211

Sanders, Jan-Stephan F. ; de Joode, Anoek A. E. ; DeSevaux, Ruud G. et al. / Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. In: Nephrology, Dialysis, Transplantation. 2016 ; Vol. 31, No. 9. pp. 1453-1459.

@article{85e2c14689c04526b35f73e109005fa2,

title = "Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial",

keywords = "ANCA, maintenance therapy, proteinase 3, relapse, vasculitis",

author = "Sanders, {Jan-Stephan F.} and {de Joode}, {Anoek A. E.} and DeSevaux, {Ruud G.} and Jan Broekroelofs and Voskuyl, {Alexandre E.} and {van Paassen}, Pieter and Kallenberg, {Cees G. M.} and Tervaert, {Jan Willem Cohen} and Stegeman, {Coen A.}",

year = "2016",

month = sep,

doi = "10.1093/ndt/gfw211",

language = "English",

volume = "31",

pages = "1453--1459",

journal = "Nephrology, Dialysis, Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "9",

}

Sanders, J-SF, de Joode, AAE, DeSevaux, RG, Broekroelofs, J, Voskuyl, AE, van Paassen, P, Kallenberg, CGM, Tervaert, JWC & Stegeman, CA 2016, 'Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial', Nephrology, Dialysis, Transplantation, vol. 31, no. 9, pp. 1453-1459. https://doi.org/10.1093/ndt/gfw211

Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. / Sanders, Jan-Stephan F.; de Joode, Anoek A. E.; DeSevaux, Ruud G. et al.

In: Nephrology, Dialysis, Transplantation, Vol. 31, No. 9, 09.2016, p. 1453-1459.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial

AU - Sanders, Jan-Stephan F.

AU - de Joode, Anoek A. E.

AU - DeSevaux, Ruud G.

AU - Broekroelofs, Jan

AU - Voskuyl, Alexandre E.

AU - van Paassen, Pieter

AU - Kallenberg, Cees G. M.

AU - Tervaert, Jan Willem Cohen

AU - Stegeman, Coen A.

PY - 2016/9

Y1 - 2016/9

KW - ANCA

KW - maintenance therapy

KW - proteinase 3

KW - relapse

KW - vasculitis

U2 - 10.1093/ndt/gfw211

DO - 10.1093/ndt/gfw211

M3 - Article

C2 - 27242368

VL - 31

SP - 1453

EP - 1459

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

SN - 0931-0509

IS - 9

ER -

Sanders J-SF, de Joode AAE, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P et al. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. Nephrology, Dialysis, Transplantation. 2016 Sep;31(9):1453-1459. doi: 10.1093/ndt/gfw211